S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

BioForce Nanosciences Stock Forecast, Price & News

+0.35 (+29.17%)
(As of 11/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
100 shs
Average Volume
3,799 shs
Market Capitalization
$23.67 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive BFNH News and Ratings via Email

Sign-up to receive the latest news and ratings for BioForce Nanosciences and its competitors with MarketBeat's FREE daily newsletter.

BioForce Nanosciences logo

About BioForce Nanosciences

BioForce Nanosciences Holdings, Inc. provides natural vitamins, minerals, nutritional supplements, powders and beverages. It markets products through social media and telemarketing. The company was founded on December 10, 1999 and is headquartered in Virginia Beach, VA.


See More Headlines

Industry, Sector and Symbol

Analytical instruments
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$20 thousand
Book Value
($0.05) per share


Net Income
$-158.41 million
Pretax Margin




Free Float
Market Cap
$23.67 million
Not Optionable

Company Calendar

Fiscal Year End


Overall MarketRank

0.33 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

BioForce Nanosciences (OTCMKTS:BFNH) Frequently Asked Questions

Who are BioForce Nanosciences' key executives?

BioForce Nanosciences' management team includes the following people:
  • Merle Ferguson, Chairman, President, CEO & Treasurer
  • Richard James Kaiser, Chief Financial Officer, Secretary & Director

Who are some of BioForce Nanosciences' key competitors?

What is BioForce Nanosciences' stock symbol?

BioForce Nanosciences trades on the OTCMKTS under the ticker symbol "BFNH."

How do I buy shares of BioForce Nanosciences?

Shares of BFNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BioForce Nanosciences' stock price today?

One share of BFNH stock can currently be purchased for approximately $1.55.

How much money does BioForce Nanosciences make?

BioForce Nanosciences has a market capitalization of $23.67 million and generates $20 thousand in revenue each year.

How many employees does BioForce Nanosciences have?

BioForce Nanosciences employs 2 workers across the globe.

What is BioForce Nanosciences' official website?

The official website for BioForce Nanosciences is www.bioforceeclipse.com.

Where are BioForce Nanosciences' headquarters?

BioForce Nanosciences is headquartered at 2020 GENERAL BOOTH BLVD UNIT 230, VIRGINIA BEACH VA, 23454.

How can I contact BioForce Nanosciences?

BioForce Nanosciences' mailing address is 2020 GENERAL BOOTH BLVD UNIT 230, VIRGINIA BEACH VA, 23454. The company can be reached via phone at (757) 306-6090, via email at [email protected], or via fax at 757-306-6092.

This page was last updated on 11/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.